Latest News and Press Releases

NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...

NAPANEE, Ontario, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. (“Lophos”) (CSE:MESC), a trailblazer in the production of Lophophora williamsii (peyote), proudly announces a significant...

NAPANEE, Ontario, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is delighted to share additional information on its wholly-owned subsidiary, Lophos...

Lophos Pharmaceuticals Corp. obtains a Controlled Substance Dealer’s License from Health Canada.

VANCOUVER, British Columbia, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is delighted to share a substantial milestone. Its wholly owned...

VANCOUVER, British Columbia, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") is pleased to announce that its common shares have been approved for listing on the...

NAPANEE, Ontario, Aug. 25, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. is pleased to announce that its wholly owned subsidiary, Lophos Pharmaceuticals Corp., has received its Controlled Substances...

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Lophos Holdings (The “Company”) is pleased to provide an update on its wholly owned subsidiary Lophos Pharmaceuticals (“Lophos”). Lophos is a psychedelic...

TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Greenridez 2.0 Acquisitions Corp. (the "Company") is pleased to announce that it has completed its acquisition of psychedelic research company Lophos...